J&J Moves To Duck Pfizer Suit Over Remicade Biosimilar
Johnson & Johnson and its subsidiary Janssen Biotech Inc. urged a Pennsylvania federal court Tuesday to toss a suit brought by Pfizer Inc. alleging the companies used anti-competitive tactics to maintain...To view the full article, register now.
Already a subscriber? Click here to view full article